SALL4 and acute myeloid leukemia: Lastly, constitutive SALL4 expression has been documented in various human myeloid and lymphoid leukemia cell lines including KG1a (AML-M0), KASUMI-1 (AML-M2), HL-60 (AML- M2/M3), NB-4 (AML M3), THP1 (AML-M5), TEX (FUS/TLS-ERG oncogene immortalized AML), K562 (CML/AML M6), RPMI-8226 (myeloma), LAMA84 (CML-acute phase), BV173 (B-ALL), REH (ALL), NALM6 (ALL), 697 (pre-B ALL), BLIN-1 (pre-B ALL) and JURKAT (T cell leukemia) [34, 58, 61–65].